FMC news

FMC reported a $106 million third-quarter revenue drop, primarily due to commercial actions taken in October, and revised its full-year free cash flow outlook, saying performance will improve in 2027.

FMC Corporation ratified an amendment to its credit agreement to facilitate the FMC India Reorganization and subsequent disposition of FMC India, New Dutch BV and New US LLC were added as subsidiary guarantors.

FMC Corp revised third-quarter revenue and Adjusted EBITDA estimates downward and announced $625 million to $675 million in charges to lower channel inventory prices and modify US pricing models amidst weaker-than-expected demand.

FMC Corp enters into an investor agreement with Tessenderlo Group NV dated September 23, 2026, regarding a prior purchase of over 30 million shares.

FMC Corporation and Tessenderlo Group NV entered into a Stock Purchase Agreement for the sale of Common Stock. The agreement outlines terms for the Investor to purchase shares and references antitrust regulations applicable to the transaction.

FMC Corporation entered into a supply and license agreement with Corteva Agriscience, receiving $200 million contingent upon specific milestones. The company amended its credit agreement to release collateral and grant security interests in related intellectual property.

FMC Corporation has entered into a definitive agreement to sell the FMC Stine Research Center in Newark, Delaware, to ERCOR Elkton, LLC. This divestiture of non-core real estate aligns with broader restructuring goals.

FMC Corporation priced $1.2 billion of 8.000% senior secured notes due 2031 at par, with proceeds to refinance maturing 3.200% notes and repay debt. The offering demonstrates the company's ability to access capital markets and manage its debt maturity profile.

FMC Corporation plans a private offering of $750 million in senior secured notes to refinance maturing 3.2% notes due October 2026 and repay credit facility borrowings. The offering is subject to market conditions with no assurance of completion.